The Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299) is a bipartisan bill to ensure seniors save on drug costs without sacrificing care. It keeps treatment close to home, lowers out-of-pocket costs, and protects individualized care plans.

This bill ensures:

• Your care stays close, in your community. Clinics can keep their doors open by maintaining fair reimbursement for selected Medicare Part B drugs.
• Lower costs for you. Coinsurance is based on the lower Medicare Fair Price (MFP), so you pay less for life-saving treatments.
• Savings without harm. Instead of cutting payments to your doctor, the bill requires manufacturers to provide drug rebates directly to Medicare. Patient and clinical care teams are not pawns in a tug-of-war.
• Protection for personalized treatment. Your doctor can prescribe the right therapy, in the right setting, at the right time.

Medicare’s new drug pricing rules don’t just affect today’s treatments—they could also slow tomorrow’s breakthroughs.

When price controls take effect too early in a drug’s lifecycle, manufacturers often scale back or stop investing in additional clinical trials for new indications. These follow-on studies are critical because they frequently lead to expanded uses of existing therapies, giving more patients access to life-saving options without waiting for an entirely new drug to be discovered and developed.

If these incentives disappear, patients may lose access to future treatment advances that improve survival and quality of life. H.R. 4299 helps preserve these incentives by fixing reimbursement issues without undermining the research pipeline. Protecting fair payment for clinics means protecting the future of cancer care.

TAKE ACTION to protect Patient Access to Complex Therapies now and in the future.